Position in VIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,642,471
+$2,988,779 QoQ
Shares Held
1,142,539
+18.3% QoQ
Ownership
0.675%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 237 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Derivatives in VIR
reported options exposure · as of Sep 30, 2021CallValue
$587,520
CallShares
13,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. VIR ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in VIR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,642,471 | 1,142,539 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,653,692 | 965,814 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,613,373 | 930,908 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,289,611 | 400,983 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,145,531 | 425,701 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,050,179 | 470,707 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,421,389 | 193,650 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,521,079 | 336,593 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,580,786 | 851,774 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,511,264 | 1,136,354 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,532,588 | 152,345 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,142,796 | 762,305 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,362,325 | 340,902 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,188,064 | 609,715 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,904,378 | 509,853 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $8,407,813 | 436,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,016,161 | 196,944 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,890,323 | 501,179 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,724,500 | 303,905 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $587,520 | 13,500 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $8,067,866 | 185,383 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,048,105 | 233,674 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $9,166,357 | 178,786 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,226,201 | 45,788 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $857,802 | 24,987 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,899,204 | 46,356 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $59,115 | 1,725 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||